Immuno-oncology applications using next generation sequencing
US10636512B2 · kind B2 · utility
1Cited by
23References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2018 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Aug 6, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B5/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are systems and methods for generating an immune-oncology profile from a biological sample. The immune-oncology profile can include the proportion or percentage of immune cells, expression of immune escape genes, and/or mutational burden. The immune-oncology profile may allow the generation of classifiers for making prognostic or diagnostic predictions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.